Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.58 |
| ▸ | ACHE | P22303 | 2/20 | 0.58 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.44 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29472460 | 1.00 | ALDH1A1 (0.58) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| SCHEMBL14310903 | 0.86 | ACKR3 (0.53) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| SCHEMBL2444201 | 0.85 | ALDH1A1 (0.51) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| SCHEMBL13426298 | 0.85 | ALDH1A1 (0.51) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| Hydrochloric Acid SCHEMBL2447950 | 0.84 | ALDH1A1 (0.50) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| SCHEMBL19636619 | 0.83 | TERT (0.48) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| SCHEMBL19633172 | 0.83 | ALDH1A1 (0.49) | ALDH1A1LMNASLC22A1ACHESLC22A2 | |
| SCHEMBL20338043 | 0.82 | SCN9A (0.49) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 | |
| SCHEMBL19611848 | 0.82 | TERT (0.49) | ALDH1A1LMNABLMKDM4ESMN1; SMN2 | |
| SCHEMBL9796585 | 0.82 | ALDH1A1 (0.67) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676618-A1 | IMPROVING THE ANALYSIS OF OLIGOSACCHARIDES USING A LIQUID CHROMATOGRAPHY SYSTEM AND A CHROMATOGRAPHIC COLUMN IN WHICH THE LC SYSTEM AND COLUMN'S INTERNAL METAL SURFACE HAS BEEN MODIFIED WITH A LAYER OF INERT MATERIAL | Waters Technologies Corporation (US) | 2026-01-14 | — | — | EP | claimed |
| WO-2024189500-A1 | IMPROVING THE ANALYSIS OF OLIGOSACCHARIDES USING A LIQUID CHROMATOGRAPHY SYSTEM AND A CHROMATOGRAPHIC COLUMN IN WHICH THE LC SYSTEM AND COLUMN'S INTERNAL METAL SURFACE HAS BEEN MODIFIED WITH A LAYER OF INERT MATERIAL | WATERS TECHNOLOGIES CORPORATION (US) | 2024-09-19 | — | — | WO | claimed |
| US-20240302334-A1 | ANALYSIS OF OLIGOSACCHARIDES USING A LIQUID CHROMATOGRAPHY SYSTEM AND A CHROMATOGRAPHIC COLUMN IN WHICH THE LC SYSTEM AND COLUMN'S INTERNAL METAL SURFACE HAS BEEN MODIFIED WITH A LAYER OF INERT MATERIAL | WATERS TECHNOLOGIES CORPORATION (US) | 2024-09-12 | — | — | US | claimed |
| CN-114213394-B | Synthesis method of N-sugar analysis reagent fluorogenic substrate | 上海瀚诺威生物科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114213394-A | Synthesis method of N-sugar analysis reagent fluorogenic substrate | 上海瀚诺威生物科技有限公司 | 2022-03-22 | — | — | CN | claimed |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-13 | — | — | US | claimed |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-31 | — | — | US | claimed |
| EP-3472132-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | Waters Technologies Corporation (US) | 2019-04-24 | — | — | EP | claimed |
| WO-2017222954-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2017-12-28 | — | — | WO | claimed |
| US-20250085275-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2025-03-13 | — | — | US | disclosed |
| US-20240302334-A1 | ANALYSIS OF OLIGOSACCHARIDES USING A LIQUID CHROMATOGRAPHY SYSTEM AND A CHROMATOGRAPHIC COLUMN IN WHICH THE LC SYSTEM AND COLUMN'S INTERNAL METAL SURFACE HAS BEEN MODIFIED WITH A LAYER OF INERT MATERIAL | WATERS TECHNOLOGIES CORPORATION (US) | 2024-09-12 | — | — | US | disclosed |
| US-11747310-B2 | Methods for liquid chromatography calibration for rapid labeled N-glycans | WATERS TECHNOLOGIES CORPORATION (US) | 2023-09-05 | — | — | US | disclosed |
| US-11747310-B2 | Methods for liquid chromatography calibration for rapid labeled N-glycans | WATERS TECHNOLOGIES CORPORATION (US) | 2023-09-05 | — | — | US | disclosed |
| US-20230256109-A1 | Trans-Cyclooctene Bioorthogonal Agents and Uses in Cancer and Immunotherapy | TAMBO, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20160139136-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2016-05-19 | — | — | US | disclosed |
| EP-2990401-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MASS SPECTROMETRY SIGNALS | Waters Technologies Corporation (US) | 2016-03-02 | — | — | EP | disclosed |
| US-20140350263-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2014-11-27 | — | — | US | disclosed |
| US-20140350263-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2014-11-27 | — | — | US | disclosed |
| US-20140242709-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2014-08-28 | — | — | US | disclosed |
| US-20140179011-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230256109-A1 | Trans-Cyclooctene Bioorthogonal Agents and Uses in Cancer and Immunotherapy | ICOS, CD74, PBK | ALDH1A1 3456/4885LMNA 4665/4885SLC22A1 2920/4885 |
| US-20140350263-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | FUT5, FUT6, CSGALNACT1 | ALDH1A1 4000/4885LMNA 1566/4885SLC22A1 4586/4885 |
| US-20190331669-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | ALDH1A1 264/4885LMNA 1541/4885SLC22A1 4092/4885 |
| US-20250085275-A1 | FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES THROUGH REDUCTIVE AMINATION FOR ENHANCED MS SIGNALS | FUT5, FUT6, OGT | ALDH1A1 264/4885LMNA 1541/4885SLC22A1 4092/4885 |
| US-11747310-B2 | Methods for liquid chromatography calibration for rapid labeled N-glycans | DDOST, STT3B, CSGALNACT1 | ALDH1A1 1045/4885LMNA 586/4885SLC22A1 1849/4885 |
| US-20160139136-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | FUT5, FUT6, CSGALNACT1 | ALDH1A1 4000/4885LMNA 1566/4885SLC22A1 4586/4885 |
| US-11061023-B2 | Fluorescence tagging of glycans and other biomolecules through reductive amination for enhanced MS signals | FUT5, FUT6, OGT | ALDH1A1 264/4885LMNA 1541/4885SLC22A1 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.